Abstract
Outcome after surgical treatment has been based predominantly on objective criteria. A more global assessment is necessary which also includes patient-reported health-related quality of life. The literature concerning investigations on quality of life measurements in surgery and follow-up in colorectal cancer is reviewed. Only a few studies are published; the results are conflicting and the methodology questionable. Therefore, it is concluded that there is a strong need for further research in this field.
Keywords: Colorectal cancer surgery, quality of life assessments, follow-up
Current Cancer Therapy Reviews
Title: Quality of Life Assessments in Colorectal Cancer Surgery. A Review
Volume: 4 Issue: 4
Author(s): Per Jess
Affiliation:
Keywords: Colorectal cancer surgery, quality of life assessments, follow-up
Abstract: Outcome after surgical treatment has been based predominantly on objective criteria. A more global assessment is necessary which also includes patient-reported health-related quality of life. The literature concerning investigations on quality of life measurements in surgery and follow-up in colorectal cancer is reviewed. Only a few studies are published; the results are conflicting and the methodology questionable. Therefore, it is concluded that there is a strong need for further research in this field.
Export Options
About this article
Cite this article as:
Jess Per, Quality of Life Assessments in Colorectal Cancer Surgery. A Review, Current Cancer Therapy Reviews 2008; 4 (4) . https://dx.doi.org/10.2174/157339408786413335
DOI https://dx.doi.org/10.2174/157339408786413335 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Berberine as a Promising Safe Anti-Cancer Agent- Is there a Role for Mitochondria?
Current Drug Targets Human Reduced Folate Carrier Gene and Transcript Variants: Functional, Physiologic, and Pharmacologic Consequences
Current Pharmacogenomics Non-Genotoxic p53-Activators and their Significance as Antitumor Therapy of Future
Current Medicinal Chemistry Identification of Potential MEK1 Inhibitors by Pharmacophore-based Virtual Screening and MD Simulations
Letters in Drug Design & Discovery Preclinical and Clinical Studies of Novel Breast Cancer Drugs Targeting Molecules Involved in Protein Kinase C Signaling, the Putative Metastasis-Suppressor Gene Cap43 and the Y-box Binding Protein-1
Current Medicinal Chemistry MUC1 is a Promising Therapeutic Target for Prostate Cancer Therapy
Current Cancer Drug Targets Pharmacogenetic Variation and Metformin Response
Current Drug Metabolism AMPK as a New Attractive Therapeutic Target for Disease Prevention: The Role of Dietary Compounds AMPK and Disease Prevention
Current Drug Targets Role of Imaging in Testicular Cancer
Current Medical Imaging Personalized Medicine in Oncology: A Personal View with Myths and Facts
Current Clinical Pharmacology VEGF and Colon Cancer Growth Beyond Angiogenesis: Does VEGF Directly Mediate Colon Cancer Growth Via a Non-angiogenic Mechanism?
Current Pharmaceutical Design Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer
Current Medicinal Chemistry Gene Delivery for Cancer Therapy
Current Drug Delivery Improvement of Adoptive Cellular Immunotherapy of Human Cancer Using Ex-Vivo Gene Transfer
Current Gene Therapy Mutation Mechanisms of Breast Cancer among the Female Population in China
Current Bioinformatics Radiation Dosimetry Aspects of <sup>177</sup>Lu
Current Radiopharmaceuticals Bioactive Coumarins from Marine Sources: Origin, Structural Features and Pharmacological Properties
Current Topics in Medicinal Chemistry Development of <sup>18</sup>F-Labeled PET Probes for Imaging Cell Proliferation
Current Topics in Medicinal Chemistry Imatinib Mesylate for the Treatment of Solid Tumours: Recent Trials and Future Directions
Current Enzyme Inhibition Treatment of Colorectal Liver Metastases: A Review
Reviews on Recent Clinical Trials